T cells expressing a HER2-specific chimeric antigen receptor as treatment for breast cancer
Crossref DOI link: https://doi.org/10.1007/s00432-023-04996-5
Published Online: 2023-07-04
Published Print: 2023-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xie, Xinshan
Li, Xiaobin
Liu, Gang
Zhao, Hui
Zhou, Zhenlong
Xiong, Sheng
Text and Data Mining valid from 2023-07-04
Version of Record valid from 2023-07-04
Article History
Received: 11 May 2023
Accepted: 15 June 2023
First Online: 4 July 2023
Declarations
:
: The authors declare no competing interests.